Sorrento Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 15 | $0.61 | $0.91 | $0.76 |
Sorrento Therapeutics, Inc. Earnings Date And Information
Sorrento Therapeutics, Inc. last posted its earnings results on Tuesday, February 28th, 2023. The company reported $-0.49768 earnings per share for the quarter, missing analysts' consensus estimates of $-0.19 by $0.30768. The company had revenue of 15.03 M for the quarter and had revenue of 62.84 M for the year. Sorrento Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Sorrento Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.
Sorrento Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2023 | Q2 2023 | -$0.17 | $22.60 M | $15.03 M | ||
| 05/15/2023 | Q1 2023 | -$0.26 | $16.25 M | |||
| 03/15/2023 | Q4 2022 | -$0.50 | $15.59 M | |||
| 11/08/2022 | Q3 2022 | -$0.25 | -$0.20 | 0.05 | $13.60 M | $17.40 M |
| 08/15/2022 | Q2 2022 | -$0.23 | -$0.55 | -0.32 | $14.81 M | $11.46 M |
| 05/05/2022 | Q1 2022 | -$0.30 | -$0.12 | 0.18 | $18.39 M | |
| 03/11/2022 | Q4 2021 | -$0.29 | -$0.47 | -0.18 | $13.08 M | |
| 11/05/2021 | Q3 2021 | -$0.21 | -$0.40 | -0.19 | $12.06 M | |
| 08/06/2021 | Q2 2021 | -$0.20 | -$0.57 | -0.37 | $13.51 M | |
| 05/05/2021 | Q1 2021 | $0.38 | $0.01 | -0.37 | $14.26 M | |
| 02/19/2021 | Q4 2020 | -$0.23 | -$0.28 | -0.05 | $11.51 M | |
| 11/06/2020 | Q3 2020 | -$0.33 | $11.75 M | |||
| 08/04/2020 | Q2 2020 | -$0.24 | -$0.36 | -0.12 | $9.01 M | |
| 05/11/2020 | Q1 2020 | -$0.20 | -$0.36 | -0.16 | $7.72 M | |
| 03/02/2020 | Q4 2019 | -$0.34 | $13.03 M | |||
| 11/08/2019 | Q3 2019 | -$0.49 | $5.78 M | |||
| 08/09/2019 | Q2 2019 | -$0.40 | -$0.46 | -0.06 | $6.48 M | |
| 05/15/2019 | Q1 2019 | -$0.35 | -$0.88 | -0.53 | $6.14 M | |
| 04/29/2019 | Q4 2018 | -$0.41 | $6.93 M | |||
| 11/09/2018 | Q3 2018 | -$0.19 | -$0.40 | -0.21 | $4.11 M |
Sorrento Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Sorrento Therapeutics, Inc.'s earnings date?
Sorrento Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.
-
How can I listen to Sorrento Therapeutics, Inc.'s earnings conference call?
The conference call for Sorrento Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Sorrento Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Sorrento Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Sorrento Therapeutics, Inc. generate each year?
Sorrento Therapeutics, Inc. (:SRNE) has a recorded annual revenue of $62.84 M.
-
How much profit does Sorrento Therapeutics, Inc. generate each year?
Sorrento Therapeutics, Inc. (:SRNE) has a recorded net income of $62.84 M. Sorrento Therapeutics, Inc. has generated $-1.33 earnings per share over the last four quarters.
-
What is Sorrento Therapeutics, Inc.'s price-to-earnings ratio?
Sorrento Therapeutics, Inc. (:SRNE) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.
